XiFin’s Payor Rate Transparency Monitor Helps Clinical Labs Compare In-Network Rates
The free online tool can set a foundation for renewed reimbursement strategies and contract negotiations with insurance carriers
The free online tool can set a foundation for renewed reimbursement strategies and contract negotiations with insurance carriers
As of August 31, 2022, labs and other providers must use the new ABN labeled with the appropriate federal OMB Number (0938-0566) and CMS-R-131 to ensure they can bill Medicare beneficiaries for any lab tests or other services that Medicare doesn’t cover.
According to a recent OIG report, CMS is not doing a good job collecting the Medicare overpayments OIG auditors are uncovering. However, CMS recently rejected almost all of the recommendations in that report, suggesting all is not well between the two federal agencies.
The new report could be a turning point in the battle to curb payor abuse of preauthorization requirements.
Here are the two key CLFS changes, set to take effect on July 1, 2022, that your billing staff needs to know about.
Here’s a look at the key takeaways from the Dec. 30 OIG report on Medicare Part B spending on lab testing.